Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:RCT Economics

14 Publications found

A systematic review: Cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes.

b

Endocrinology, diabetes & metabolism

November 1, 2022

p Diabetes

c Change patient management Economics RCT
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial.

b

Rheumatology and therapy

September 1, 2021

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Economics RCT
Cost-effectiveness of financial incentives to improve glycemic control in adults with diabetes: A pilot randomized controlled trial.

b

PloS one

January 1, 2021

p Diabetes

c Change patient management Clinical outcomes Economics RCT
Noninvasive Cardiac Testing vs Clinical Evaluation Alone in Acute Chest Pain: A Secondary Analysis of the ROMICAT-II Randomized Clinical Trial.

b

JAMA internal medicine

February 1, 2018

p Cardiovascular Disease

c Change patient management Clinical outcomes Economics Operational efficiencies RCT
Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial.

b

AIDS (London, England)

July 17, 2017

p HIV POCT

c Change patient management Clinical outcomes Economics Highlighted RCT
Cost effectiveness of high-sensitivity troponin compared to conventional troponin among patients presenting with undifferentiated chest pain: A trial based analysis.

b

International journal of cardiology

July 1, 2017

p Cardiovascular Disease

c Clinical outcomes Economics RCT
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab.

b

Digestive diseases and sciences

September 1, 2015

p Therapeutic drug monitoring

c Economics RCT
Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial.

b

Gut

June 1, 2014

p Therapeutic drug monitoring

c Clinical outcomes Economics RCT
Interhospital variation in the RATPAC trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers).

b

Emergency medicine journal : EMJ

March 1, 2012

p Cardiovascular Disease

c Economics Highlighted RCT
Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial.

b

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine

May 1, 2011

p Cardiovascular Disease

c Economics RCT